Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
This study record was previously posted/updated by Alkermes, Inc. As of 29 Oct 2019, the sponsorship of the trial was transferred to Biogen along with responsibility for subsequent updates to the record.
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Has a body-mass Index (BMI) \>/=18.0 and \</=32.0 kg/m2
Agrees to use an acceptable method of contraception for the duration of the study and for 30 days after any study drug administration
Additional criteria may apply
You may not be if
Is currently pregnant or breastfeeding
Has a lifetime history of menopausal hot flashes
Has a clinically significant medical condition
Has had a clinically significant illness in the 30 days prior to first study drug administration
Has had a serious infection (eg, pneumonia or septicemia) within the 3 months prior to study drug administration
Has had any vaccinations in the 4 weeks prior to inpatient admission
Has a lifetime history of diabetes
Additional criteria may apply
Clareo Health | A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults
